Cargando…
Remdesivir in COVID-19 management: availability and relevance to low- and middle-income countries
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7592638/ https://www.ncbi.nlm.nih.gov/pubmed/33139967 http://dx.doi.org/10.1007/s40267-020-00791-1 |
_version_ | 1783601226340892672 |
---|---|
author | Adhikari, Sugat Khadka, Sitaram Dahal, Sadhana Shrestha, Dhan Bahadur Shahi, Janak Bajgain, Yogesh |
author_facet | Adhikari, Sugat Khadka, Sitaram Dahal, Sadhana Shrestha, Dhan Bahadur Shahi, Janak Bajgain, Yogesh |
author_sort | Adhikari, Sugat |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7592638 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-75926382020-10-29 Remdesivir in COVID-19 management: availability and relevance to low- and middle-income countries Adhikari, Sugat Khadka, Sitaram Dahal, Sadhana Shrestha, Dhan Bahadur Shahi, Janak Bajgain, Yogesh Drugs Ther Perspect Commentary Springer International Publishing 2020-10-28 2021 /pmc/articles/PMC7592638/ /pubmed/33139967 http://dx.doi.org/10.1007/s40267-020-00791-1 Text en © Springer Nature Switzerland AG 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Commentary Adhikari, Sugat Khadka, Sitaram Dahal, Sadhana Shrestha, Dhan Bahadur Shahi, Janak Bajgain, Yogesh Remdesivir in COVID-19 management: availability and relevance to low- and middle-income countries |
title | Remdesivir in COVID-19 management: availability and relevance to low- and middle-income countries |
title_full | Remdesivir in COVID-19 management: availability and relevance to low- and middle-income countries |
title_fullStr | Remdesivir in COVID-19 management: availability and relevance to low- and middle-income countries |
title_full_unstemmed | Remdesivir in COVID-19 management: availability and relevance to low- and middle-income countries |
title_short | Remdesivir in COVID-19 management: availability and relevance to low- and middle-income countries |
title_sort | remdesivir in covid-19 management: availability and relevance to low- and middle-income countries |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7592638/ https://www.ncbi.nlm.nih.gov/pubmed/33139967 http://dx.doi.org/10.1007/s40267-020-00791-1 |
work_keys_str_mv | AT adhikarisugat remdesivirincovid19managementavailabilityandrelevancetolowandmiddleincomecountries AT khadkasitaram remdesivirincovid19managementavailabilityandrelevancetolowandmiddleincomecountries AT dahalsadhana remdesivirincovid19managementavailabilityandrelevancetolowandmiddleincomecountries AT shresthadhanbahadur remdesivirincovid19managementavailabilityandrelevancetolowandmiddleincomecountries AT shahijanak remdesivirincovid19managementavailabilityandrelevancetolowandmiddleincomecountries AT bajgainyogesh remdesivirincovid19managementavailabilityandrelevancetolowandmiddleincomecountries |